z-logo
open-access-imgOpen Access
Effect of Controlled Release/Extended Release Metoprolol on Carotid Intima-Media Thickness in Patients With Hypercholesterolemia
Author(s) -
Olov Wiklund,
Johannes Hulthe,
John Wikstrand,
Caroline Schmidt,
SvenOlof Olofsson,
Göran Bondjers
Publication year - 2002
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/hs0202.102332
Subject(s) - medicine , metoprolol , placebo , randomization , cardiology , concomitant , intima media thickness , randomized controlled trial , aspirin , common carotid artery , stroke (engine) , cholesterol , beta blocker , gastroenterology , carotid arteries , alternative medicine , pathology , mechanical engineering , heart failure , engineering
Beta-adrenergic blockade has in several studies been shown to improve survival after myocardial infarction. In animal experiments beta-blockers have also shown an antiatherosclerotic effect. The aim of this study was to test the hypothesis that the beta-blocker metoprolol succinate controlled release/extended release (CR/XL), when given to patients with hypercholesterolemia on concomitant lipid-lowering therapy, provides an additional antiatherosclerotic effect to that provided by the statins, measured as carotid intima-media thickness (IMT).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom